
 |
 |  |  |  |  |
 |  |
 |
To discuss the different ways Dyadic can work with you to break the bottlenecks in your genomic research and development programs, please contact:
genomics@dyadic.com
1-561-743-8333
To discuss the different ways Dyadic can collaborate with you on research projects of mutual interest, please contact:
technology@dyadic.com
1-561-743-8333
To discuss different ways that Dyadic can work with you to optimize and scale up your fermentation processes, please contact:
manufacturing@dyadic.com
1-561-743-8333
|
 |
Alternatively, you can submit the
Information Request Form. |
|  |  |  |  |  |  |  |
 |
| | 
Dyadic is interested in strategic partnerships with industry leaders in various sectors, including pharmaceuticals, agricultural and food products, chemicals and fibers, diagnostics, health and beauty aids, and animal feed and health products.
Utilizing its proprietary integrated C1 technology, Dyadic works with its partners to discover new biomaterials; accelerate product development; develop new products; improve production yields; lower costs and reduce waste; enhance the quality of end products; enhance the intellectual property position of its partners’ gene discoveries and gene products; and manufacture biological products.
The business relationship with Dyadic can cover all aspects of the process from gene and protein discovery to commercial scale manufacturing for a partner, or just any one aspect of this R&D and commercialization process. (view diagram)
Partnerships can take any appropriate form, including but not limited to:
- Funded R&D with license for commercial rights for resulting products (with or without Dyadic manufacturing products for the partner)
- Joint ventures in defined fields for discovering, developing, manufacturing and commercializing products emanating from the application of Dyadic’s integrated C1 high throughput robotic screening and protein expression systems
Dyadic is developing functional biomolecule libraries for other companies to access – under suitable business arrangements – to screen for products of commercial value. When desired by a business partner, Dyadic will screen microorganisms and other diverse biological sources for novel eukaryotic genes and proteins of commercial value.
Some of the industries expected to benefit most from collaborations with Dyadic for eukaryotic gene discovery and expression include the pharmaceutical, agriculture and food product, chemical and fiber, diagnostic, health and beauty aid, and animal health and feed industries.
Dyadic is also interested in collaboration with independent researchers, as well as scientists at research institutions, universities and commercial establishments where a research partnership is of mutual benefit.
If you are interested in Dyadic’s manufacturing capabilities for your biological products, please visit manufacturing services.
|  |